Keyword

seladelpar

Description: Seladelpar is a selective PPAR-delta agonist drug studied as a treatment for primary biliary cholangitis.
Wikidata ID: wiki/Q27268037
OpenAlex ID: keywords/seladelpar
2024 · Gideon M. Hirschfield, Christopher L. Bowlus, et al. · New England Journal of Medicine · 324
2022 · Christopher L. Bowlus, Michael R. Galambos, et al. · Journal of Hepatology · 92
2023 · Andreas E. Kremer, Marlyn J. Mayo, et al. · Hepatology · 71
2024 · Cynthia Levy, Christopher L. Bowlus · Hepatology · 44
2023 · Marlyn J. Mayo, John M. Vierling, et al. · Alimentary Pharmacology & Therapeutics · 41
2024 · Colleen M. Hayes, Gina M. Gallucci, et al. · Hepatology Communications · 35
2025 · Cynthia Levy, Palak J. Trivedi, et al. · The American Journal of Gastroenterology · 31
2024 · Stefano Fiorucci, Ginevra Urbani, et al. · Cells · 31
2024 · Bernd Schnabl · New England Journal of Medicine · 26
2024 · Sheridan M. Hoy · Drugs · 23
2023 · Yun-Jung Choi, Jeff D. Johnson, et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 17
2022 · Aaron Wetten, David Emrys Jeffreys Jones, et al. · Expert Opinion on Investigational Drugs · 17
Works count: 297
Citation count: 1,929
Year
Topic
Type